Cargando…
SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
SMARCA4/BRG1 and SMARCA2/BRM, the two mutually exclusive catalytic subunits of the BAF complex, display a well-established synthetic lethal relationship in SMARCA4-deficient cancers. Using CRISPR-Cas9 screening, we identify SMARCA4 as a novel dependency in SMARCA2-deficient esophageal squamous cell...
Autores principales: | Ehrenhöfer-Wölfer, Katharina, Puchner, Teresa, Schwarz, Cornelia, Rippka, Janine, Blaha-Ostermann, Silvia, Strobl, Ursula, Hörmann, Alexandra, Bader, Gerd, Kornigg, Stefan, Zahn, Stephan, Sommergruber, Wolfgang, Schweifer, Norbert, Zichner, Thomas, Schlattl, Andreas, Neumüller, Ralph A., Shi, Junwei, Vakoc, Christopher R., Kögl, Manfred, Petronczki, Mark, Kraut, Norbert, Pearson, Mark A., Wöhrle, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691015/ https://www.ncbi.nlm.nih.gov/pubmed/31406271 http://dx.doi.org/10.1038/s41598-019-48152-x |
Ejemplares similares
-
RIOK1 kinase activity is required for cell survival irrespective of MTAP status
por: Hörmann, Alexandra, et al.
Publicado: (2018) -
Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells
por: Lieb, Simone, et al.
Publicado: (2019) -
Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023) -
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022) -
High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)